Source: Annals of the Rheumatic Diseases. Conference titles: Annual European Congres of Rheumatology. Unidade: FM
Subjects: ESTUDOS RANDOMIZADOS, ESTUDOS PROSPECTIVOS, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, R. B. C. et al. Cyclophosphamide (CFM) and prednisone: a prospective randomized controlled study for SSC lung and skin disease. Annals of the Rheumatic Diseases. London: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 15 dez. 2025. , 2008APA
Souza, R. B. C., Dominiciano, D. S., Borges, C. T. L., Kairalla, R. A., Parra, E., Capelozzi, V. L., & Bonfá. E.,. (2008). Cyclophosphamide (CFM) and prednisone: a prospective randomized controlled study for SSC lung and skin disease. Annals of the Rheumatic Diseases. London: Faculdade de Medicina, Universidade de São Paulo.NLM
Souza RBC, Dominiciano DS, Borges CTL, Kairalla RA, Parra E, Capelozzi VL, Bonfá. E. Cyclophosphamide (CFM) and prednisone: a prospective randomized controlled study for SSC lung and skin disease. Annals of the Rheumatic Diseases. 2008 ; 67( suppl. 2): 505.[citado 2025 dez. 15 ]Vancouver
Souza RBC, Dominiciano DS, Borges CTL, Kairalla RA, Parra E, Capelozzi VL, Bonfá. E. Cyclophosphamide (CFM) and prednisone: a prospective randomized controlled study for SSC lung and skin disease. Annals of the Rheumatic Diseases. 2008 ; 67( suppl. 2): 505.[citado 2025 dez. 15 ]
